Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms
Seug Yun Yoon, Sung-Yong Kim
Korean J Intern Med. 2023;38(6):810-817. Published online 2023 Nov 1 DOI: https://doi.org/10.3904/kjim.2023.333
Citations to this article as recorded by 
Treatment with ropeginterferon alfa-2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one-year results from a phase 2 study
Seug Yun Yoon, Sung-Eun Lee
Blood Research.2024;[Epub] CrossRef
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, Moumita Saha, Rajiv Patel
Bioorganic Chemistry.2024; 152: 107696. CrossRef